Central AsianResearch Index

FERROPTOSIS IN MACROPHAGE ACTIVATION SYNDROME AND ADULT-ONSET STILL’S DISEASE

Ferroptosis is an iron-dependent, lipid peroxidation-driven form of regulated cell death which is increasingly recognized for its role in inflammatory and degenerative diseases. It shares mechanistic links with pyroptosis through reactive oxygen species and membrane lipid damage. This paper aims to explore the potential role of ferroptosis in hyperferritinemic conditions, particularly in macrophage activation syndrome and adult-onset Still’s disease (AOSD), and to assess whether targeting ferroptotic pathways may offer therapeutic benefits. Experimental studies suggest that ferroptosis contributes to immune cell dysfunction and organ damage via oxidative stress. Glutathione peroxidase 4 is a key ferroptosis regulator that also plays a role in pyroptosis. Ferroptosis inhibitors such as ferrostatin-1 and iron chelators have shown protective effects in sepsis and multiorgan failure models. In AOSD, a hyperferritinemic condition, lipid peroxidation products have been associated with disease severity, indicating a potential role of ferroptosis in its pathogenesis. Therefore, ferroptosis may represent a mechanistic bridge between iron metabolism, oxidative stress, and autoinflammatory responses. Further research is warranted to determine whether ferroptosis-targeted therapies can improve outcomes in MAS and related disorders.

Сведения

Опубликовано
2025 · Т. 6, № 2, С. 100-104
Язык
Английский
ISSN
2708-9800
Издатель
South Kazakhstan Medical Academy